drugset / Trial / NCT02305394

Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy

NCT02305394 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Electroconvulsive therapy (ECT) is an effective treatment for depression compared with the current antidepressant agents,but the most important side effect is cognitive dysfunction. The purpose of this study is to determine whether subanesthetic dose of ketamine combined with propofol is superior to propofol anesthesia alone in improving cognitive function in depressive patients undergoing ECT.

Timeline

Start
2015-01
Primary completion
2016-12
Completion
2017-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.3 mg/kg Intravenous
Background Propofol Small molecule 1.5 mg/kg Intravenous